AJNR Am J Neuroradiol
- IVANIDZE J, Gardella J, Olson A, Sun SM, et al
PET-guided Assessment of Amyloid Clearance and Outcomes in a Real-World Cohort of
Patients with Alzheimer Disease undergoing Anti-Amyloid Therapy.
AJNR Am J Neuroradiol. 2026 Apr 29:ajnr.A9387. doi: 10.3174/ajnr.A9387.
- PYATIGORSKAYA N, Boughdad S, Bera G, Giron A, et al
[18F]FDG-PET/MRI Performance in Head-and-Neck Cancers at Initial Staging,
Restaging and Follow Up.
AJNR Am J Neuroradiol. 2026 Apr 25:ajnr.A9377. doi: 10.3174/ajnr.A9377.
Ann Nucl Med
- MAHFOUZ RA, Mohammad MG, Ouf SG, Zidan ASA, et al
Coronary microvascular injury detection and prediction after successful primary
percutaneous coronary intervention: non-invasive assessment using single photon
emission tomography myocardial perfusion imaging.
Ann Nucl Med. 2026 Apr 27. doi: 10.1007/s12149-026-02208.
- SHIMIZU K, Matsumoto K, Omasa W, Akamatsu G, et al
Error analysis of cerebral blood flow and oxygen metabolism in three-dimensional
(15)O-gas positron emission tomography acquisition.
Ann Nucl Med. 2026 Apr 27. doi: 10.1007/s12149-026-02217.
- SANTO G, Rosarno H, Restuccia A, Cascini GL, et al
Biochemical failure after radical prostatectomy with PSA = 1 ng/mL: prediction of
PSMA-positive metastatic disease.
Ann Nucl Med. 2026;40:521-531.
Appl Radiat Isot
- SENISIK AM, Kokkulunk HT, Yuksel M
Quantitative evaluation of patient-emitted radiation in dual-injection Tc-99m
MIBI myocardial perfusion scintigraphy: A multiregional, multi-distance, and
scenario-based safety analysis.
Appl Radiat Isot. 2026;233:112554.
- RENALDIN E, Mateu I, Braccini S, Zhang H, et al
Production of the Auger-electron emitter (161)Ho for nuclear medicine using
proton beams.
Appl Radiat Isot. 2026;234:112622.
- ZOLGHADRI S, Karimian A, Moghaddasi A, Yousefnia H, et al
Preclinical and human dosimetric aspects of [(113m)In]In-BPAMD: A new agent for
SPECT imaging of bone metastases.
Appl Radiat Isot. 2026;234:112623.
- ZHU J, Ge M, He S, Zhang N, et al
Synthesis and evaluation of (18)F-labeled small-molecular radiotracers as PET
agents for imaging PD-L1 expression.
Appl Radiat Isot. 2026;234:112665.
Circ Cardiovasc Imaging
- SCHINDLER TH, Okzan E
Integrating PET-Determined Global and Focal Impairment of Myocardial Flow Reserve
to Enhance Cardiovascular Prognostication?
Circ Cardiovasc Imaging. 2026 May 1:e019868. doi: 10.1161/CIRCIMAGING.126.019868
- SAYED A, Moody JB, Poitrasson-Riviere A, Renaud JM, et al
Diffuse Perfusion Impairment Versus Global Myocardial Flow Reserve and Focal
Perfusion Impairments in Patients Undergoing (82)Rb-PET Imaging.
Circ Cardiovasc Imaging. 2026 May 1:e019246. doi: 10.1161/CIRCIMAGING.125.019246
Hum Brain Mapp
- RADANOVIC A, Jamison KW, Kang Y, Tozlu C, et al
Longitudinal Multimodal Neuroimaging After Traumatic Brain Injury.
Hum Brain Mapp. 2026;47:e70534.
J Nucl Med
- CHAUHAN A, Hendifar AE, El-Haddad G, Soares HP, et al
The Equivalents Are Coming! Developing a Shared Nomenclature for
Radiopharmaceutical Therapy of Neuroendocrine Tumors, Prostate Cancer, and
Beyond.
J Nucl Med. 2026 Apr 30:jnumed.126.272026. doi: 10.2967/jnumed.126.272026.
- LIU H, Qu W, Liang D, Yu X, et al
Performance Evaluation of SmartBrain: A Wearable PET System for Human Brain
Imaging.
J Nucl Med. 2026 Apr 30:jnumed.125.271350. doi: 10.2967/jnumed.125.271350.
- BROSCH-LENZ J, Buther F, Oehler S, Ciamarone A, et al
Dynamics, Pharmacokinetics, and Dosimetry of First-in-Human
[(68)Ga]Ga-OncoACP3-DOTA PET in Patients with Prostate Cancer.
J Nucl Med. 2026 Apr 30:jnumed.125.271933. doi: 10.2967/jnumed.125.271933.
- COCHET A, Besson V, Bertaut A, Fouquier A, et al
(18)F-FDG and (18)F-Fluorocholine PET as Prognostic Biomarkers in Patients with
Advanced Hepatocellular Carcinoma Treated with Sorafenib: A Prospective
Multicenter Study.
J Nucl Med. 2026 Apr 30:jnumed.125.271382. doi: 10.2967/jnumed.125.271382.
Neurologia (Engl Ed)
- MINGUILLON PEREIRO AM, Garcia-de Soto J, Pouso-Diz J, Juiz Fernandez A, et al
A cohort approach to focal cortical dysplasia type II: A 10-year management
overview at an adult epilepsy referral centre.
Neurologia (Engl Ed). 2026;41:501937.
Nucl Med Commun
- SINGH J, Singh N, Pereira M, Shivdasani D, et al
Role of fluorodeoxyglucose positron emission tomography scan in assessing the
extent of myocardial viability in patients with left ventricular dysfunction and
its impact on patient outcome.
Nucl Med Commun. 2026 Apr 28. doi: 10.1097/MNM.0000000000002168.
- HAROON A, Almuhaideb A, Adeleke S, Davis LM, et al
18F choline PET/MR to assess clinically significant disease in prostate cancer:
correlation with maximum and total cancer core length obtained via template
mapping biopsies.
Nucl Med Commun. 2026 Apr 28. doi: 10.1097/MNM.0000000000002158.
- MOSTERT JM, Oei EHG, van Beekveld DWJ, Biswal S, et al
[18F]fluorodeoxyglucose PET/MRI for nononcological musculoskeletal indications:
reference uptake values in the asymptomatic lumbar spine and example comparison
to a low back pain patient.
Nucl Med Commun. 2026 Apr 27. doi: 10.1097/MNM.0000000000002164.
Phys Med Biol
- LIU Q, Scheins JJ, Pfaehler E, Ciantar KG, et al
Comparison of physical approaches to inter-crystal scattering in a
staggered-layer scintillation PET detector: a simulation study.
Phys Med Biol. 2026 Apr 30. doi: 10.1088/1361-6560.
- SALVADORI J, Allegrini O, Florian R, Poterszman N, et al
[177Lu]Lu-PSMA extravasation: from quantitative imaging to clinical guidelines.
Phys Med Biol. 2026;71.
Semin Nucl Med
- LAURI C, Aarntzen E, Glaudemans AW, Levi J, et al
Radiopharmaceuticals for imaging T-cells.
Semin Nucl Med. 2026 Apr 27:S0001-2998(26)00050.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016